Janssen R&D and HealthVerity Announce RWD Partnership Using Millions of Deidentified Patient Records

HealthVerity has announced a partnership with Janssen Research & Development. HealthVerity’s Identity, Privacy, Governance and Exchange (IPGE) platform includes 330 million deidentified patient records and allows for large-scale real world data (RWD) curation, access, and research.

“The integrated multi-modal linkage capabilities of RWD to clinical trial patients allows the creation of longitudinal patient journeys supporting numerous use cases including Long Term Follow Up (LTFU) and Phase 4 studies.” Read more here.

(Source: Cision PR Newswire, 9/22/21)